leisure time -WSS

leisure time

author：leisure time 2025-09-27 12:55:05 - browse：43883

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

explore

WSS

Achieving telehealth equity for people with hearing loss

AI gets buy

Surgery pushed Ben Carson to fame

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Congress: Prevent baby formula shortages by passing a new bill

focus

leisure time

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

Hospitals need to get ahead of regulations on climate change

Medical records are filled with copy

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Jerome Adams on the need for new antivirals for Covid

The Biogen Aduhelm mess could happen again

Peter Hotez and the public health issue of online harassment

Readout LOUD: Venture capital, Gilead, and more M&A

Supreme Court strikes down use of affirmative action

Surgery pushed Ben Carson to fame

leisure time

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

A single Democrat is willing to weaken Medicare negotiation power

Bird flu makes raw milk dangerous to consume, mouse study finds

The CDC's new social media misinformation war

U.S. death rates show how politics are affecting public health

What’s missing from the debate over nursing home staff minimums

hotspot

entertainment

explore

entertainment